A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Trial Centre Location Province Status
CISSS du Bas-Saint-Laurent - Hôpital régional Rimouski Rimouski Quebec Closed
CIUSSS du Saguenay Lac-St-Jean - Hôpital de Chicoutimi Chicoutimi Quebec Closed

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society